life one origin ginkgo biloba 2500
australian antarctic ocean bio-technology pty ltd - ginkgo biloba -
medical oxygen min 99.5 %v/v inhalation gas
air products ireland limited - oxygen - inhalation gas - min 99.5 %v/v - medical gases
inomax nitric oxide 800 ppm medicinal gas for inhalation cylinder
ikaria australia pty ltd - nitric oxide, quantity: 0.08 % w/w - gas, medicinal - excipient ingredients: nitrogen - inomax?, in conjunction with ventilatory support and other appropriate agents, is indicated -,- for the treatment of term and near-term ( greater than 34 weeks) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension, in order to improve oxygenation and to reduce the need for extracorporeal membrane oxygenation.,- to selectively decrease pulmonary arterial pressure in patients with perioperative pulmonary hypertension in conjunction with heart surgery
air liquide air medical ep grade (medical air) air 100% v/v gas cylinder
air liquide healthcare pty ltd - air, quantity: 100 % v/v - gas, medicinal - excipient ingredients: - for normal respiration. in anaesthetic equipment as a carrier gas during surgery. for nebulisation of inhaled drugs when oxygen supplementation is not required.
coregas pty ltd medical air 100% v/v gas in gas cylinder
coregas pty ltd - air, quantity: 100 % v/v - gas, medicinal - excipient ingredients: - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)
life hand sanitizer solution 80 %
life products, tanzania - h, sanitizer - solution - 80 %
life scope methylated spirit solution 70
life scope tanzania, tanzania - ethanol - solution - 70
methoxyflurane medical developments md&p 99.9%, 3 ml inhalation vapour, liquid
medical developments md&p limited - methoxyflurane - inhalation vapour, liquid - 99.9 %, 3 millilitre(s) - methoxyflurane
kepivance
a menarini australia pty ltd - palifermin -
kepivance
swedish orphan biovitrum ab (publ) - palifermin - mucositis - all other therapeutic products - kepivance is indicated to decrease the incidence, duration and severity of oral mucositis in adult patients with haematological malignancies receiving myeloablative radiochemotherapy associated with a high incidence of severe mucositis and requiring autologous-haematopoietic-stem-cell support.